867 related articles for article (PubMed ID: 18421428)
1. Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma.
Wang K; Liu CT; Wu YH; Feng YL; Bai HL
Adv Ther; 2008 Apr; 25(4):342-54. PubMed ID: 18421428
[TBL] [Abstract][Full Text] [Related]
2. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
3. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.
Hoshino M; Nakamura Y; Hamid QA
J Allergy Clin Immunol; 2001 Jun; 107(6):1034-8. PubMed ID: 11398081
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma.
Chetta A; Zanini A; Foresi A; D'Ippolito R; Tipa A; Castagnaro A; Baraldo S; Neri M; Saetta M; Olivieri D
Clin Exp Allergy; 2005 Nov; 35(11):1437-42. PubMed ID: 16297139
[TBL] [Abstract][Full Text] [Related]
6. Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma.
Feltis BN; Wignarajah D; Reid DW; Ward C; Harding R; Walters EH
Thorax; 2007 Apr; 62(4):314-9. PubMed ID: 17105777
[TBL] [Abstract][Full Text] [Related]
7. Budesonide/formoterol combination therapy as both maintenance and reliever medication in moderate-to-severe asthma: a real-life effectiveness study of Malaysian patients.
Loh LC; Lim BK; Raman S; Vijayasingham P; Mohd Yusuf S
Med J Malaysia; 2008 Aug; 63(3):188-92. PubMed ID: 19248687
[TBL] [Abstract][Full Text] [Related]
8. [Effects of budesonide on HIF-1α and VEGF expression and airway remodeling in an asthmatic mouse model].
Sun Y; Wang JR; Han XZ; Li HB; Sun LF; Chen X; Feng YZ
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):622-7. PubMed ID: 22898286
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients.
Essilfie-Quaye S; Ito K; Ito M; Kharitonov SA; Barnes PJ
Respir Med; 2011 Dec; 105(12):1784-9. PubMed ID: 21903370
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component.
Yuksel H; Kose C; Yilmaz O; Ozbilgin K; Degirmenci PB; Pinar E; Kirmaz C
Clin Exp Allergy; 2007 Aug; 37(8):1183-8. PubMed ID: 17651148
[TBL] [Abstract][Full Text] [Related]
11. Budesonide/formoterol (Symbicort) for asthma.
Med Lett Drugs Ther; 2008 Feb; 50(1279):9-11. PubMed ID: 18264031
[No Abstract] [Full Text] [Related]
12. Inhibition of angiogenesis by IL-32: possible role in asthma.
Meyer N; Christoph J; Makrinioti H; Indermitte P; Rhyner C; Soyka M; Eiwegger T; Chalubinski M; Wanke K; Fujita H; Wawrzyniak P; Bürgler S; Zhang S; Akdis M; Menz G; Akdis C
J Allergy Clin Immunol; 2012 Apr; 129(4):964-73.e7. PubMed ID: 22336080
[TBL] [Abstract][Full Text] [Related]
13. [Effects of leukotriene receptor antagonists on vascular endothelial growth factor and its receptors in a sensitized rat model].
Yang HS; Wang L; Yang W; Guan JT; Ma JY; Su Y
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Mar; 32(3):177-81. PubMed ID: 19575935
[TBL] [Abstract][Full Text] [Related]
14. Relationship between vascular endothelial growth factor and angiopoietin-2 in asthmatics before and after inhaled beclomethasone therapy.
Nomura S; Kanazawa H; Hirata K; Iwao H; Yoshikawa J
J Asthma; 2005 Mar; 42(2):141-6. PubMed ID: 15871447
[TBL] [Abstract][Full Text] [Related]
15. Asp-Tyr-Leu-Lys tetrapeptide inhibits airway inflammation in toluene-2,4-diisocyanate-induced asthma mice.
Ahn MH; Park BJ; Kwon JH; An SH; Park JW; Jang AS; Rhim T; Park CS
Clin Exp Allergy; 2008 Jun; 38(6):1025-32. PubMed ID: 18498544
[TBL] [Abstract][Full Text] [Related]
16. Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma.
Hoshino M; Ohtawa J
Respirology; 2012 May; 17(4):639-46. PubMed ID: 22248352
[TBL] [Abstract][Full Text] [Related]
17. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus.
Skevaki CL; Christodoulou I; Spyridaki IS; Tiniakou I; Georgiou V; Xepapadaki P; Kafetzis DA; Papadopoulos NG
Clin Exp Allergy; 2009 Nov; 39(11):1700-10. PubMed ID: 19549024
[TBL] [Abstract][Full Text] [Related]
18. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma.
Feltis BN; Wignarajah D; Zheng L; Ward C; Reid D; Harding R; Walters EH
Am J Respir Crit Care Med; 2006 Jun; 173(11):1201-7. PubMed ID: 16528018
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of human calcium-activated chloride channel 1 is correlated with mucus overproduction in the airways of Chinese patients with chronic obstructive pulmonary disease.
Wang K; Feng YL; Wen FQ; Chen XR; Ou XM; Xu D; Yang J; Deng ZP
Chin Med J (Engl); 2007 Jun; 120(12):1051-7. PubMed ID: 17637221
[TBL] [Abstract][Full Text] [Related]
20. Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma.
Wang K; Liu CT; Wu YH; Feng YL; Bai HL; Ma ES; Wen FQ
Acta Pharmacol Sin; 2011 Jan; 32(1):126-32. PubMed ID: 21170080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
